AUTOMATED WHOLE BREAST ULTRASOUND a Supplementary Screening Exam

Total Page：16

File Type：pdf, Size：1020Kb

AUTOMATED WHOLE BREAST ULTRASOUND A Supplementary Screening Exam EFW Radiology provides comprehensive for Women with Dense Breasts diagnostic breast imaging, including: • Mammography • iCAD Second Look® for enhanced breast cancer detection on all mammograms • Breast Density Assessment on every mammogram • Automated Whole Breast Ultrasound (AWBU) screening for dense breasts • Ultrasound-guided biopsy • Breast MRI To book an appointment please call (403) 541-1200 For more information and a complete list of services and clinic locations, please visit efwrad.com. efwrad.com AWBU0513 WHAT IS AUTOMATED WHOLE FATTY BREASTS ASSESSING BREAST DENSITY BREAST ULTRASOUND (AWBU)? Spotting tiny cancers in Breast density refers to the volume of the breast AWBU is the latest technology in imaging the mammogram of a fatty that is composed of fat versus dense tissue. EFW the entire breast with ultrasound. This exam breast is easier because provides a standardized, objective assessment of is complementary to a mammogram and is cancer shows up white on breast density using a computerized model. especially benefi cial to women with dense breast dark, fatty breast tissue, as tissue, as dense tissue can make small cancers shown on the right. RESEARCH SHOWS: diffi cult to visualize using mammography alone. • early detection of breast cancer is essential. • detecting cancers at a small size saves lives. THE EXAM • AWBU can detect 3-4 additional cancers AN AWBU EXAM: DENSE BREASTS per 1,000 women with dense breast tissue screened with both modalities, as compared • does not involve breast compression, Cancers are hidden and, to mammography alone (and the cancers injection or radiation. therefore, harder to fi nd at detected have been small, invasive cancers). • is performed while lying in a comfortable a small size in dense breast position and is painless. tissue because both appear white on a mammogram. • provides images of the entire breast that AVERAGE SIZE OF CANCER are carefully reviewed by a radiologist with DETECTED BY… expertise in breast imaging. • permanently records the results for future needs. THE FACTS ULTRASOUND AWBU has been proven to fi nd small cancers With ultrasound, cancers Self-exam Mammography Ultrasound on that are not detectable by mammography in appear dark against the (approx. 25mm) (approx. 17mm) dense breast (approx. 10mm) women with dense breasts. If you have dense white background of dense breasts, this test is recommended in addition to breast tissue, making the 6mm your screening mammogram. cancer more visible. The “Talk to your doctor about developing a image on the right shows a 6mm cancer which was specialized program for early detection not detected by a previous that meets your individual needs and mammogram. gives you peace of mind.” – Breastcancer.org.

Copy Link

Recommended publications

Future of Breast Elastography
Future of breast elastography Richard Gary Barr1,2 1Department of Radiology, Northeastern Ohio Medical University, Rootstown, OH; 2Southwoods Imaging, Youngstown, OH, USA REVIEW ARTICLE Both strain elastography and shear wave elastography have been shown to have high sensitivity https://doi.org/10.14366/usg.18053 pISSN: 2288-5919 • eISSN: 2288-5943 and specificity for characterizing breast lesions as benign or malignant. Training is important for Ultrasonography 2019;38:93-105 both strain and shear wave elastography. The unique feature of benign lesions measuring smaller on elastography than B-mode imaging and malignant lesions appearing larger on elastography is an important feature for characterization of breast masses. There are several artifacts which can contain diagnostic information or alert to technique problems. Both strain and shear wave elastography continue to have improvements and new techniques will soon be available for Received: September 21, 2018 clinical use that may provide additional diagnostic information. This paper reviews the present Revised: January 4, 2019 Accepted: January 4, 2019 state of breast elastography and discusses future techniques that are not yet in clinical practice. Correspondence to: Richard Gary Barr, MD, PhD, Keywords: Breast; Elasticity imaging techniques; Strain; Shear wave; Strain ratio; Southwoods Imaging, 7623 Market Street, Youngstown, OH 44512, USA Breast neoplasms Tel. +1-330-965-5100 Fax. +1-330-965-5109 E-mail: [email protected] Introduction The use of palpation to determine the stiffness of a lesion has been used since the time of the ancient Greeks and Egyptians [1]. Stiff, non-mobile lesions of the breast have a high probability of being malignant.
[Show full text]
Breast Scintimammography
CLINICAL MEDICAL POLICY Policy Name: Breast Scintimammography Policy Number: MP-105-MD-PA Responsible Department(s): Medical Management Provider Notice Date: 11/23/2020 Issue Date: 11/23/2020 Effective Date: 12/21/2020 Next Annual Review: 10/2021 Revision Date: 09/16/2020 Products: Gateway Health℠ Medicaid Application: All participating hospitals and providers Page Number(s): 1 of 5 DISCLAIMER Gateway Health℠ (Gateway) medical policy is intended to serve only as a general reference resource regarding coverage for the services described. This policy does not constitute medical advice and is not intended to govern or otherwise influence medical decisions. POLICY STATEMENT Gateway Health℠ does not provide coverage in the Company’s Medicaid products for breast scintimammography. The service is considered experimental and investigational in all applications, including but not limited to use as an adjunct to mammography or in staging the axillary lymph nodes. This policy is designed to address medical necessity guidelines that are appropriate for the majority of individuals with a particular disease, illness or condition. Each person’s unique clinical circumstances warrant individual consideration, based upon review of applicable medical records. (Current applicable Pennsylvania HealthChoices Agreement Section V. Program Requirements, B. Prior Authorization of Services, 1. General Prior Authorization Requirements.) Policy No. MP-105-MD-PA Page 1 of 5 DEFINITIONS Prior Authorization Review Panel – A panel of representatives from within the Pennsylvania Department of Human Services who have been assigned organizational responsibility for the review, approval and denial of all PH-MCO Prior Authorization policies and procedures. Scintimammography A noninvasive supplemental diagnostic testing technology that requires the use of radiopharmaceuticals in order to detect tissues within the breast that accumulate higher levels of radioactive tracer that emit gamma radiation.
[Show full text]
Breast Imaging H
BREAST IMAGING H. Lee Moffitt Cancer Center and Research Institute Rotation Director: Margaret Szabunio, M.D. General Goals : On this rotation, the resident will learn to interpret screening mammograms and to perform diagnostic mammography and ultrasound examinations of the breast. The resident will learn to formulate appropriate differential diagnoses and recommendations for various breast pathologies. The resident will also learn mammographic, ultrasound and MR breast biopsy techniques. Daily Work : The resident rotation begins after morning conference has concluded. In this rotation the resident shall learn BIRADS nomenclature and become proficient in using the PENRAD system for reporting. The resident will also learn the difference between screening and diagnostic mammography and how to perform a diagnostic work-up. (S)he will become familiarized with mammographic positioning and technique and quality assurance including MQSA and ACR requirements. The resident will learn to interpret mammographic images and the use of additional mammographic views for problem solving. (S)he will learn when and how to employ sonography in patient evaluation. The resident is REQUIRED to attend Thursday morning breast interdisciplinary conference. Preparing and reviewing cases for this conference is highly recommended. The resident will assist with and perform needle localizations, breast biopsy and cyst aspiration procedures using mammographic, stereotactic and sonographic techniques for each. The resident is expected to identify proper indications and contraindications for each procedure and how to identify and manage complications. The resident is expected to understand and complete informed consent for image guided breast procedures. On occasion, the resident may observe or assist with ductography procedures. Opportunity to observe and assist with MR guided breast procedures may also be available.
[Show full text]
Understanding Cost & Coverage Issues with Diagnostic Breast Imaging
Understanding Cost & Coverage Issues with Diagnostic Breast Imaging JANUARY 2019 The following report represents key findings from The Martec Group’s primary and secondary research efforts. The team was instructed to explore the cost and coverage issue with breast diagnostic imaging in order to equip Susan G. Komen with the information necessary to strategize efforts at the state and federal levels. TABLE OF CONTENTS: I. A Brief Summary of Findings ................................................................................................................... 3 II. Project Background ..................................................................................................................................... 3 III. Study Objectives ........................................................................................................................................... 3 IV. Research Methodology .............................................................................................................................. 3 V. Patient Perspective ...................................................................................................................................... 4 VI. Health/Insurance Professional Perspective ...................................................................................... 5 VII. Cost Analysis .................................................................................................................................................. 6 VIII. Study Conclusions .......................................................................................................................................
[Show full text]
Breast MRI: New and Abbreviated Protocols
Breast MRI: New and Abbreviated Protocols Christopher Comstock M.D. Department of Radiology Memorial Sloan-Kettering Cancer Center Topics • What is our goal? • Current status of screening • How do we change screening • Abbreviated Breast MRI (AB-MR) • EA1141 AB-MR Trial • Multiparametric Breast MRI Beyond the scope of this talk! • The debate over screening the benefit of mammography, particularly for women in their forties. What is Our Goal? • Decrease breast cancer mortality • Reduction in the morbidities associated with surgery and chemotherapy • Finding breast cancers at a smaller size and earlier stage leads to a reduction in mortality and the use of less aggressive therapies Reservoir of Breast Cancer Present in 1000 Women Being Screened • Is it 30, 40, 50, 60 or more breast cancers per 1000 women? • Depends on risk of population • Detection level (size and stage) depends on modality and frequency of screening Reservoir of Breast Cancer Present in 1000 Women Being Screened Tomo plus WBUS The Dissemination of Medical Technologies into Clinical Practice • Innovations medical in technology and quality of information are the sole driving force in the acceptance and adoption of new technologies • The dissemination of medical technologies depends on the social, political and ideological context into which they are introduced Much Can Be Learned From the History of Mammography • Despite improvements in technology, mammography languished from 1930s to 1970 – 1930-1950 Stafford L. Warren, Jacob Gershon-Cohen and Raul Leborgne – 1950s Improved techniques, Robert Egan • The production of better data alone did not eliminate the role that economics, authority and ideology played “TO SEE TODAY WITH THE EYES OF TOMORROW” A HISTORY OF SCREENING MAMMOGRAPHY.
[Show full text]
Breast Elastography – Ultrasound Or Magnetic Resonance
Medical Policy Joint Medical Policies are a source for BCBSM and BCN medical policy information only. These documents are not to be used to determine benefits or reimbursement. Please reference the appropriate certificate or contract for benefit information. This policy may be updated and is therefore subject to change. *Current Policy Effective Date: 7/1/21 (See policy history boxes for previous effective dates) Title: Breast Elastography – Ultrasound or Magnetic Resonance Description/Background In the United States, about 1 in 8 women will develop invasive breast cancer over the course of her lifetime. In 2020, is it estimated that there will be over 280,000 new cases of invasive breast cancer diagnosed in women and over 2,600 new cases of invasive breast cancer in men.1 Breast cancer is the most common cancer in women worldwide.2 Mammography remains the generally accepted standard diagnostic test for breast cancer screening and diagnosis. The incidence of breast cancer has led to research on new diagnostic imaging techniques for early diagnosis. Elasticity is the property of a substance to be deformed in response to an external force and to resume its original size and shape when the force is removed. In evaluation of superficial tissue such as skin, breast or prostate, manual palpation can distinguish normal tissue from stiffer tissue. Elastography is a noninvasive technique that evaluates the elastic properties, or stiffness of tissues, and its application for diagnosing breast cancer is based on the principle that malignant tissue is less elastic than normal, healthy breast tissue. Elastography has been investigated as an additive technique to increase the specificity of ultrasound and magnetic resonance imaging.
[Show full text]
Breast Ultrasound Accreditation Program Requirements
Breast Ultrasound Accreditation Program Requirements OVERVIEW ........................................................................................................................................................................... 1 MANDATORY ACCREDITATION TIME REQUIREMENTS .......................................................................................................... 2 PERSONNEL QUALIFICATIONS ..................................................................................................................................... 2 INTERPRETING PHYSICIAN .................................................................................................................................................... 2 SONOGRAPHER/TECHNOLOGIST ........................................................................................................................................... 5 EQUIPMENT ......................................................................................................................................................................... 5 QUALITY CONTROL .......................................................................................................................................................... 6 ACCEPTANCE TESTING ......................................................................................................................................................... 6 ANNUAL SURVEY ................................................................................................................................................................
[Show full text]
Evaluation of Nipple Discharge
New 2016 American College of Radiology ACR Appropriateness Criteria® Evaluation of Nipple Discharge Variant 1: Physiologic nipple discharge. Female of any age. Initial imaging examination. Radiologic Procedure Rating Comments RRL* Mammography diagnostic 1 See references [2,4-7]. ☢☢ Digital breast tomosynthesis diagnostic 1 See references [2,4-7]. ☢☢ US breast 1 See references [2,4-7]. O MRI breast without and with IV contrast 1 See references [2,4-7]. O MRI breast without IV contrast 1 See references [2,4-7]. O FDG-PEM 1 See references [2,4-7]. ☢☢☢☢ Sestamibi MBI 1 See references [2,4-7]. ☢☢☢ Ductography 1 See references [2,4-7]. ☢☢ Image-guided core biopsy breast 1 See references [2,4-7]. Varies Image-guided fine needle aspiration breast 1 Varies *Relative Rating Scale: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate Radiation Level Variant 2: Pathologic nipple discharge. Male or female 40 years of age or older. Initial imaging examination. Radiologic Procedure Rating Comments RRL* See references [3,6,8,10,13,14,16,25- Mammography diagnostic 9 29,32,34,42-44,71-73]. ☢☢ See references [3,6,8,10,13,14,16,25- Digital breast tomosynthesis diagnostic 9 29,32,34,42-44,71-73]. ☢☢ US is usually complementary to mammography. It can be an alternative to mammography if the patient had a recent US breast 9 mammogram or is pregnant. See O references [3,5,10,12,13,16,25,30,31,45- 49]. MRI breast without and with IV contrast 1 See references [3,8,23,24,35,46,51-55].
[Show full text]
Screening Automated Whole Breast Ultrasound
Screening Automated Whole Breast Ultrasound Screening Automated Whole Breast Ultrasound Stanford now offers screening automated whole breast ultrasound (SAWBU) at our Stanford Medicine Cancer Center Palo Alto location. This is an optional test that can be used as a supplement to screening mammography in women with mammographically dense breasts. It can find cancers that cannot be seen on mammograms due to overlap with dense breast tissue. Stanford uses automated whole breast technique, a new method developed for accuracy and efficiency. Who is a candidate for SAWBU What will happen during the How is SAWBU exam is examination? SAWBU examination? different? This is an optional test to supplement You will lie on your back, and gel will Screening automated screening mammography in women be applied to your breast. whole breast ultrasound who: uses sound waves (no radi- A large ultrasound handpiece will be • Undergo routine screening with ation) to create 3D pictures placed on the breast, and the system mammography. of the breast tissue, using will automatically take a “sweep” • Have no current signs or a new automated method that obtains ultrasound images of symptoms of breast cancer. developed for accuracy and the tissue from top to bottom. The • Have mammographically dense efficiency. handpiece will be repositioned to take (heterogeneously or extremely other “sweeps” to include all of the It can find cancers that dense) breasts. breast tissue. cannot be seen on mam- • Are not at “high risk" undergoing mograms alone due to supplemental screening with An exam of both breasts takes less overlap with dense breast breast MRI. Screening ultra- than 20 minutes to obtain.
[Show full text]
Evaluation of the Quantitative Accuracy of a Commercially-Available Positron Emission Mammography Scanner
The Texas Medical Center Library DigitalCommons@TMC The University of Texas MD Anderson Cancer Center UTHealth Graduate School of The University of Texas MD Anderson Cancer Biomedical Sciences Dissertations and Theses Center UTHealth Graduate School of (Open Access) Biomedical Sciences 8-2010 EVALUATION OF THE QUANTITATIVE ACCURACY OF A COMMERCIALLY-AVAILABLE POSITRON EMISSION MAMMOGRAPHY SCANNER Adam Springer Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations Part of the Diagnosis Commons, Equipment and Supplies Commons, and the Other Medical Sciences Commons Recommended Citation Springer, Adam, "EVALUATION OF THE QUANTITATIVE ACCURACY OF A COMMERCIALLY-AVAILABLE POSITRON EMISSION MAMMOGRAPHY SCANNER" (2010). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access). 64. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/64 This Thesis (MS) is brought to you for free and open access by the The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at DigitalCommons@TMC. It has been accepted for inclusion in The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access) by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. EVALUATION OF THE QUANTITATIVE ACCURACY OF A COMMERCIALLY- AVAILABLE POSITRON EMISSION MAMMOGRAPHY SCANNER
[Show full text]
Commercial Reimbursement and Utilization for Invenia ABUS (Automated Breast Ultrasound)
Commercial Reimbursement and Utilization for Invenia ABUS (Automated Breast Ultrasound) Background interpreting physician, referring physician/Health Care Provider (HCP), and patient.6 Specifically, the MQSA encourages education More than one-half of women younger than 50 years old and and outreach to patients from medical/scientific organizations, approximately one-third of women 50 years and older have industry, and interpreting physicians. In addition, outreach to dense breasts in the US.1 Higher breast density is associated referring physicians is encouraged from professional organizations with decreased mammographic sensitivity and specificity and and Continuing Medical Education (CME) providers.6 increased breast cancer risk.2 Due to the shortcomings of mammography in this population of women, an individualized Despite widely available options for additional screening and multimodal screening approach is recommended to improve the legislation mandating density inform, uptake and adoption of early detection of breast cancer. No clinical guidelines explicitly supplemental screening has lagged. In addition to knowledge recommend use of supplemental breast cancer screening on gaps, one study identified reimbursement uncertainties (e.g. women with dense breasts,3 but as of March 2018, 33 states have billing, coding and coverage) as a key factor for slow uptake. In enacted legislation requiring that breast density, in addition to 2015, the CPT® codebook was updated to include two new codes mammography results, be reported to women undergoing such for breast ultrasound, CPT 76641 and 76642, for complete and procedures; additional states have introduced or are currently limited exams, respectively.7 These codes replaced CPT 76645. working on legislation.4 Most states require specific density The new and old codes alike do not differentiate the technology inform language distinguishing dense (i.e., BI-RADS® C and D) used to perform an exam (handheld vs.
[Show full text]
Shear Wave Elastography As an Early Indicator of Breast Cancer in A
ISSN: 2378-3656 Altunkeser and Arslan. Clin Med Rev Case Rep 2019, 6:259 DOI: 10.23937/2378-3656/1410259 Volume 6 | Issue 3 Clinical Medical Reviews Open Access and Case Reports CAse RepoRt Shear Wave Elastography as an Early Indicator of Breast Cancer in a Breastfeeding Patient: A Case Report and Literature Review Ayşegül Altunkeser and Fatma Zeynep Arslan* Check for Department of Radiology, Konya Training and Research Hospital, University of Health Science, Turkey updates *Corresponding author: Fatma Zeynep Arslan, MD, Konya Training and Research Hospital, University of Health Science, Hacı Şaban Mah, Meram Yeni Yol Caddesi, No: 97, PC: 42090, Meram, Konya, Turkey, Tel: 0506-438-24-30, Fax: 0-332- 323-67-23 our hospital complaining from pain in the right breast. Abstract In the young patient with no history of cancer in the Shear wave elastography (SWE) is a relatively new and family; The patient was breasfeeding and labaratuary highly effective method to reveal mechanical features of tissue by demonstrating quantitative elasticity value. The findings were normal. On physical examination, a hard morphological features including margin of the lesion, ori- mass was palpated in her right breast. A hypoechoic entation, shape and border are considered in differentiation mass lesions was sonographically detected on the right of breast lesions on USG. It is a known fact that malignant breast in a diameter with 31 × 24 mm (Figure 1). SWE lesions are usually palpated as a hard mass in the physi- cal examination. A qualitative broad information can obtain was performed to obtain additional information about about the tissue elasticity by integrating SWE examination mass lesion.
[Show full text]